NO883381L - PROCEDURE FOR THE PREPARATION OF N - (((4-HYDROSY-PYRROLIDIN-2-ON-1-YL) -ACETYL) -GYLCINAMIDE. - Google Patents

PROCEDURE FOR THE PREPARATION OF N - (((4-HYDROSY-PYRROLIDIN-2-ON-1-YL) -ACETYL) -GYLCINAMIDE.

Info

Publication number
NO883381L
NO883381L NO88883381A NO883381A NO883381L NO 883381 L NO883381 L NO 883381L NO 88883381 A NO88883381 A NO 88883381A NO 883381 A NO883381 A NO 883381A NO 883381 L NO883381 L NO 883381L
Authority
NO
Norway
Prior art keywords
acetyl
alkyl ester
glycine
pyrrolin
temperatures
Prior art date
Application number
NO88883381A
Other languages
Norwegian (no)
Other versions
NO883381D0 (en
Inventor
Thomas Meul
Laurent Duc
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of NO883381D0 publication Critical patent/NO883381D0/en
Publication of NO883381L publication Critical patent/NO883381L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic

Abstract

Hytt 4-hydrokay-2-pyrrolidinonderivat oa*t fremgangsmåt* for frettstilling av detta.Cabin 4-hydrokay-2-pyrrolidinone derivative oa * t method * for removing it.

Description

Oppfinnelsen angår en ny fremgangsmåte for fremstilling av N-[(4-hydroksy-pyrrolidin-2-on-l-yl)-acetyl]-glycinamid, en analog til cerebral-virksomt oksiracetam (4-hydroksy-pyrrolidin-2-on-l-yl-acetamid), sistnevnte kjent fra Pifferi et al, Il Farmaco, Ed.Sc. 1977, 32, 602. The invention relates to a new process for the production of N-[(4-hydroxy-pyrrolidin-2-on-l-yl)-acetyl]-glycinamide, an analogue of cerebrally active oxiracetam (4-hydroxy-pyrrolidin-2-on- 1-yl-acetamide), the latter known from Pifferi et al, Il Farmaco, Ed.Sc. 1977, 32, 602.

Fra europeisk patent A 0 2 07 681 er det kjent to fremgangsmåter for fremstilling av N-[(4-hydroksypyrrolidin-2-on-l-yl)-acetyl]-glycinamid. Ifølge den første fremgangsmåte sykliseres en 2-metylpropyl-3-karbamoylmetyl-beta-hydroksy-2-(1-metyletyl)-4-okso-l-imidazolidinbutansyreester i nærvær av vann intramole-kylært til sluttproduktet. From European patent A 0 2 07 681 two methods are known for the production of N-[(4-hydroxypyrrolidin-2-on-1-yl)-acetyl]-glycinamide. According to the first method, a 2-methylpropyl-3-carbamoylmethyl-beta-hydroxy-2-(1-methylethyl)-4-oxo-1-imidazolidinebutanoic acid ester is cyclized in the presence of water intramolecularly to the final product.

Ifølge den annen fremgangsmåte omsettes dessuten 4-hydroksy-2-okso-l-pyrrolidineddiksyre med glycinamid. According to the second method, 4-hydroxy-2-oxo-1-pyrrolidineacetic acid is also reacted with glycinamide.

Begge fremgangsmåter utmerker seg på ufordelaktig måte ved meget omstendelige fremgangsmåteformer, som ikke er tenkelig i stor teknisk målestokk. Both methods are disadvantageously distinguished by very cumbersome method forms, which are not conceivable on a large technical scale.

Det var derfor en oppgave å finne en ny enkel fremgangsmåte som kunne anvendes i stor teknisk målestokk, og som ikke har de nevnte ulemper. It was therefore a task to find a new simple method that could be used on a large technical scale, and which does not have the aforementioned disadvantages.

Oppgaven kunne løses med en fremgangsmåte omfattende føl-gende trinn: a) omsetting av en (4-halogen-3-alkoksy-but-2E-ensyrealkyl-ester) med en glycinglycinalkylester til en N-[(4-alkoksy-3- pyrrolin-2-on-l-yl)acetyl]-glycinalkylester, b) videre omsetting med benzylalkohol i nærvær av en syre, midlertidig til N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinalkylester, c) amidering med ammoniakk til N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinamid, d) avspalting av den beskyttende benzylgruppe ved hydrogenolyse i nærvær av en palladiumkatalysator med hydrogen, The task could be solved with a method comprising the following steps: a) conversion of a (4-halo-3- alkoxy-but-2E-enoic acid alkyl ester) with a glycine glycine alkyl ester to a N-[(4-alkoxy-3-pyrroline -2-on-l-yl)acetyl]-glycine alkyl ester, b) further reaction with benzyl alcohol in the presence of an acid, temporarily to N-[(4-benzyloxy-3-pyrrolin-2-on-l-yl)-acetyl ]-glycine alkyl ester, c) amidation with ammonia to N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycinamide, d) removal of the protective benzyl group by hydrogenolysis in the presence of a palladium catalyst with hydrogen,

og til sluttand finally

e) reduksjon med et komplekst hydrid.e) reduction with a complex hydride.

Trinn a)Step a)

4- Halogen-3-alkoksy-but-2E-ensyrealkylesteren som anvendes som utgangsprodukt, kan hensiktsmessig fremstilles ifølge europeisk patent A 0 216 324 på enkel måte. The 4-halo-3-alkoxy-but-2E-enoic acid alkyl ester which is used as starting product can conveniently be prepared according to European patent A 0 216 324 in a simple way.

Med fordel anvendes 4-klor-3-(C-l-C2 ) -alkoksy-but-2E-ensyre-( C^ C^)-alkylesteren som utgangsprodukt, men 4-klor-3-metoksy-but-2E-ensyremetylesteren er spesielt foretrukket. The 4-chloro-3-(C-1-C2 )-Alkoxy-but-2E-enoic acid-(C1-C2)-alkyl ester is advantageously used as starting product, but the 4-chloro-3-methoxy-but-2E-enoic acid methyl ester is particularly preferred.

Som glycinglycinalkylester anvendes fortrinnsvis en (C^-C4)-laverealkylester, idet etylesteren, vanligvis i form av hydrokloridet, er spesielt foretrukket. A (C 1 -C 4 )-lower alkyl ester is preferably used as the glycine glycine alkyl ester, the ethyl ester, usually in the form of the hydrochloride, being particularly preferred.

Omsetningen skjer hensiktsmessig i nærvær av et tertiært amin, fortrinnsvis et trialkylamin, såsom trietylamin, ved temperaturer på mellom 50 og 80°C, fortrinnsvis ved 80°C. Det er likeledes fordelaktig å arbeide i cyaniderte hydrokarboner, fortrinnsvis i acetonitril, som løsningsmiddel. N-[(4-Alkoksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinalkylesteren som fremkommer etter en reaksjonstid på 4-8 timer, kan isoleres ifølge vanlig laboratoriepraksis fra reaksjonsblandingen og eventuelt renses. The reaction conveniently takes place in the presence of a tertiary amine, preferably a trialkylamine, such as triethylamine, at temperatures of between 50 and 80°C, preferably at 80°C. It is likewise advantageous to work in cyanidated hydrocarbons, preferably in acetonitrile, as solvent. The N-[(4-Alkoxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycine alkyl ester which appears after a reaction time of 4-8 hours can be isolated according to normal laboratory practice from the reaction mixture and optionally purified.

Trinn b og cSteps b and c

Trinn b og c utføres hensiktsmessig uten isolering av mellomproduktet fra trinn b i ett trinn. Selvfølgelig kan imid-lertid også isolasjon av mellomproduktet ifølge b) utføres trinnvis. Steps b and c are conveniently carried out without isolating the intermediate from step b in one step. Of course, however, isolation of the intermediate product according to b) can also be carried out in stages.

Benzylalkoholen tilsettes fortrinnsvis i et overskudd på 3-10 mol pr. mol til utgangsproduktet fra trinn a). Dessuten fungerer benzylalkoholen samtidig som løsningsmiddel for trinn The benzyl alcohol is preferably added in an excess of 3-10 mol per mol to the starting product from step a). In addition, the benzyl alcohol also acts as a solvent for steps

b) . b).

Som syre tilsettes i katalytiske mengder hensiktsmessig 5-20 mol% av en sulfonsyre, såsom for eksempel metansulfonsyre eller p-toluensulfonsyre. As acid, 5-20 mol% of a sulphonic acid, such as for example methanesulphonic acid or p-toluenesulphonic acid, is added in catalytic amounts.

Omsetningstemperaturen for innføring av de beskyttende benzylgrupper ligger hensiktsmessig på 80-120°C, fortrinnsvis 90-100°C. The reaction temperature for introducing the protective benzyl groups is suitably 80-120°C, preferably 90-100°C.

Reaksjonen utføres fortrinnsvis ved et lett undertrykk på 5-100 mbar. Herved er man sikker på at de avspaltede alkoholer med lavt kokepunkt ved denne omsetning fjernes fra likevekts-blandingen. The reaction is preferably carried out at a slight negative pressure of 5-100 mbar. This ensures that the separated alcohols with a low boiling point are removed from the equilibrium mixture during this reaction.

Etter en reaksjonstid på ca. 4 timer kan den intermediært foreliggende benzyloksypyrrolinester amideres direkte, uten isolering. Reaksjonsoppløsningen blir samtidig hensiktsmessig, eventuelt etter ytterligere fortynning, fortrinnsvis med en alkohol såsom f.eks. metanol, mettet med ammoniakk. After a reaction time of approx. 4 hours, the intermediately present benzyloxypyrroline ester can be amidated directly, without isolation. The reaction solution becomes appropriate at the same time, possibly after further dilution, preferably with an alcohol such as e.g. methanol, saturated with ammonia.

Ved temperaturer på 20-80°C kan reaksjonen betraktes som ferdig etter ca. 8-12 timer. At temperatures of 20-80°C, the reaction can be considered complete after approx. 8-12 hours.

Etter vanlig laboratoriemessig opparbeidelse og eventuelt etter ytterligere rensning kan N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinamidet oppnås. After usual laboratory work-up and possibly after further purification, the N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycinamide can be obtained.

Trinn d og eSteps d and e

Trinn d og e utføres hensiktsmessig i ett trinn, uten at man isoleres mellomproduktet fra trinn d). Avspaltingen av de beskyttende benzylgrupper skjer i nærvær av en palladiumkatalysator i mengder på 5-20 vekt%, basert på anvendt utgangsprodukt, tilveiebrakt på en vanlig bærer, fortrinnsvis på kull med hydrogen. Steps d and e are suitably carried out in one step, without isolating the intermediate product from step d). The removal of the protective benzyl groups takes place in the presence of a palladium catalyst in amounts of 5-20% by weight, based on the starting product used, provided on a common support, preferably on carbon with hydrogen.

Man arbeider hensiktsmessig ved temperaturer på 0-30°C og trykk på 1-10 bar. One works appropriately at temperatures of 0-30°C and pressure of 1-10 bar.

Det er fordelaktig å arbeide i et aprotisk løsningsmiddel med høyere dielektrisitetskonstanter, såsom dimetylacetamid eller dimetylformamid. It is advantageous to work in an aprotic solvent with higher dielectric constants, such as dimethylacetamide or dimethylformamide.

Etter 1-5 timer kan hydrogenolysen betraktes som ferdig. After 1-5 hours, the hydrogenolysis can be considered complete.

Mellomproduktet N-[(2,4-diokso-pyrrolidin-l-yl)-acetyl]-glycinamid isoleres ikke; hensiktsmessig reduseres det umiddel-bart videre med et komplekst hydrid til sluttproduktet. Som komplekse hydrider anvendes hensiktsmessig alkaliborhydridene, fortrinnsvis natriumborhydridet. The intermediate N-[(2,4-dioxo-pyrrolidin-1-yl)-acetyl]-glycinamide is not isolated; expediently, it is immediately further reduced with a complex hydride to the final product. The alkali borohydrides, preferably sodium borohydride, are suitably used as complex hydrides.

Omsetningstemperaturen velges hensiktsmessig mellom 0 og 30°C. The reaction temperature is suitably chosen between 0 and 30°C.

Fra reaksjonsblandingen kan man etter vanlig opparbeidelse få sluttproduktet N-[(4-hydroksy-pyrrolidin-2-on-l-yl)-acetyl]-glycinamid, eventuelt etter rensning, som hvitt krystallinsk produkt. From the reaction mixture, the end product N-[(4-hydroxy-pyrrolidin-2-on-l-yl)-acetyl]-glycinamide can be obtained after normal work-up, possibly after purification, as a white crystalline product.

EksempelExample

a) Fremstilling av N- f f4- metoksy- 3- pvrrolin- 2- on- l- yl)-acetyl"[ - glycinetylester a) Preparation of N-ff4-methoxy-3-pyrrolin-2-on-l-yl)-acetyl"[- glycine ethyl ester

25,6 g (0,13mol) glycinglycinetylester-hydroklorid ble suspendert i 60 ml acetonitril. Til dette ble det under til-bakeløp tilsatt 13,2 g (0,13 mol) trietylamin. Deretter ble det etter hverandre i løpet av 4 timer dryppet til 17,2 g (0,1 mol) 4-klor-3-metoksy-but-2E-ensyremetylester og 10,2 g (0,1 mol) trietylamin i flere porsjoner. 25.6 g (0.13 mol) of glycine glycine ethyl ester hydrochloride was suspended in 60 ml of acetonitrile. To this, 13.2 g (0.13 mol) of triethylamine were added under reflux. Then, over the course of 4 hours, 17.2 g (0.1 mol) of 4-chloro-3-methoxy-but-2E-enoic acid methyl ester and 10.2 g (0.1 mol) of triethylamine were added dropwise in several portions .

Løsningsmidlet ble avdestillert på rotasjonsfordamper og man fikk 150 ml vann som rest. Den vandige oppløsning ble ekstrahert 4 ganger med 50 ml metylenklorid hver gang. The solvent was distilled off on a rotary evaporator and 150 ml of water was obtained as a residue. The aqueous solution was extracted 4 times with 50 ml of methylene chloride each time.

Metylenklorid-fasen ble fraskilt, tørket over natriumsul-fat og inndampet. The methylene chloride phase was separated, dried over sodium sulfate and evaporated.

Man fikk 21,9 g råprodukt.21.9 g of crude product was obtained.

En prøve som ble omkrystallisert fra toluen, hadde et smeltepunkt på 87,5-88,5°C. A sample recrystallized from toluene had a melting point of 87.5-88.5°C.

b) c) Fremstillin<g>av N-(" ( 4- benzyloksy- 3- pyrrolin- 2- on- l- yl) - acetyl]- glycinamid b) c) Preparation<g>of N-(((4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]- glycinamide

4,7 g (18,4 mmol) N-[(4-metoksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinetylester ble oppløst i 10,8 g (100 mmol) benzylalkohol og tilsatt 0,1 g (1 mmol) metansulfonsyre. Denne reak-sjonsblanding ble omrørt i 4 timer ved 100°C og ved 20 mbar. Deretter tilsatte man 2 0 ml metanol og mettet reaksjonsoppløs-ningen med gassformig ammoniakk. Det ble omrørt ved 60°C over natten, og deretter ble metanol og benzylalkohol avdestillert i vakuum. Residuet ble omkrystallisert fra metanol. 4.7 g (18.4 mmol) of N-[(4-methoxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycine ethyl ester was dissolved in 10.8 g (100 mmol) of benzyl alcohol and added 0 .1 g (1 mmol) methanesulfonic acid. This reaction mixture was stirred for 4 hours at 100°C and at 20 mbar. 20 ml of methanol were then added and the reaction solution was saturated with gaseous ammonia. It was stirred at 60°C overnight, and then methanol and benzyl alcohol were distilled off in vacuo. The residue was recrystallized from methanol.

Man fikk 4,5 g N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-ace-tyl] -glycinamid. Smp. 169-170°C. 4.5 g of N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycinamide were obtained. Temp. 169-170°C.

<C>15<H>17N3°4(303,32) beregnet C 59,4 H 5,6 N 13,9 <C>15<H>17N3°4(303.32) calculated C 59.4 H 5.6 N 13.9

funnet C 59,0 H5,7 N 14,0found C 59.0 H5.7 N 14.0

d)e) Fremstilling av N- r( 4- hvdroksv- pyrrolidin- 2- on- l- yl)-acetyl]- glycinamid d)e) Preparation of N-r(4-hydroxy-pyrrolidin-2-on-1-yl)-acetyl]- glycinamide

4,0 g (13,2 mmol) N[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinamid ble oppløst i 50 ml dimetylacetamid og tilsatt 0,4 g palladium på kull 5%. 4.0 g (13.2 mmol) of N[(4-benzyloxy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinamide was dissolved in 50 ml of dimethylacetamide and 0.4 g of palladium was added on charcoal 5 %.

Denne blanding ble hydrogenolysert i 4 timer ved 4 bar ogThis mixture was hydrogenolyzed for 4 hours at 4 bar and

i romtemperatur med hydrogen. Deretter ble katalysatoren fraskilt ved hjelp av filter med sug og reaksjonsoppløsningen at room temperature with hydrogen. The catalyst was then separated using a filter with suction and the reaction solution

dryppet til en oppløsning av 0,3 6 g (9,5 mmol) natriumborhydrid i 25 ml dimetylacetamid ved 15°C i løpet av 1 time. dropped into a solution of 0.36 g (9.5 mmol) of sodium borohydride in 25 ml of dimethylacetamide at 15°C over 1 hour.

Det ble etter-omrørt i 1 time ved romtemperatur, og reak-sjonsoppløsningen ble surgjort med en blanding av 0,65 g maur-syre og 25 ml metanol. Løsningsmidlene ble avdampet i vann-stråle-vakuum, og residuet ble opptatt i 30 ml vann. It was then stirred for 1 hour at room temperature, and the reaction solution was acidified with a mixture of 0.65 g of formic acid and 25 ml of methanol. The solvents were evaporated in a water-jet vacuum, and the residue was taken up in 30 ml of water.

Den vandige oppløsning ble påsatt på 40 g sterkt sur kationebytter og deretter på 40 g svakt basisk anionebytter. Deretter ble den vandige oppløsning behandlet med 0,5 g aktivt kull. The aqueous solution was applied to 40 g of strongly acidic cation exchange and then to 40 g of weakly basic anion exchange. The aqueous solution was then treated with 0.5 g of activated carbon.

Etter fraskillelse av det aktive kull på filter med sug og inndamping av den vandige oppløsning fikk man 2,0 g hvitt krystallinsk produkt med smp. 153-154°C. After separation of the activated carbon on a filter with suction and evaporation of the aqueous solution, 2.0 g of white crystalline product with m.p. 153-154°C.

C8<H>13<N>3°4(215,21) beregnet C 44,7 H 6,1 N 19,5 C8<H>13<N>3°4(215.21) calculated C 44.7 H 6.1 N 19.5

funnet C 44,6 H6,3 N 19,1 found C 44.6 H6.3 N 19.1

<i>H-NMR: (DMS0-d6, 300 MHz) S i ppm<i>H-NMR: (DMS0-d6, 300 MHz) S in ppm

8,10 ^(br. t, J = 5,8 Hz, 1H)8.10 ^(br. t, J = 5.8 Hz, 1H)

7,317(br. s, 1H) 7,317(br. s, 1H)

7,06((br. s, 1H)7.06((br. s, 1H)

5,21 (d, J = 4,0 Hz, 1H) 5.21 (d, J = 4.0 Hz, 1H)

4,30 (m, 1H) 4.30 (m, 1H)

3,89 (d, J = 16,4 Hz, 1H) 3.89 (d, J = 16.4 Hz, 1H)

3,77 (d, J = 16,4 Hz, 1H) 3.77 (d, J = 16.4 Hz, 1H)

3,66 (d, J =5,8Hz, 2H) 3.66 (d, J =5.8Hz, 2H)

3,62 (dd, J = 5,5 Hz, J = 10,6 Hz, 1H)3.62 (dd, J = 5.5 Hz, J = 10.6 Hz, 1H)

3,18 (dd, J = 2,5 Hz, J = 10,6 Hz, 1H)3.18 (dd, J = 2.5 Hz, J = 10.6 Hz, 1H)

2,57 (dd, J = 7,0 Hz, J = 16,6 Hz, 1H)2.57 (dd, J = 7.0 Hz, J = 16.6 Hz, 1H)

2,09 (dd, J = 2,8 Hz, J = 16,6 Hz, 1H) 2.09 (dd, J = 2.8 Hz, J = 16.6 Hz, 1H)

Claims (5)

1. Fremgangsmåte for fremstilling av N[(4-hydroksy-pyrrolidin-2-on-l-yl)-acetyl]-glycinamid ifølge formelen 1. Process for the production of N[(4-hydroxy-pyrrolidin-2-on-1-yl)-acetyl]-glycinamide according to the formula karakterisert ved følgende trinn: a) en (4-halogen-3-alkoksy-but-2E-ensyrealkylester) omsettes med en glycinglycinalkylester til en N-[(4-alkoksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinalkylester, b) denne får reagere videre med benzylalkohol i nærvær av en syre, til mellomproduktet N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinalkylester, c) denne omsettes så med ammoniakk til N-[(4-benzyloksy-3-pyrrolin-2-on-l-y1)-acetyl]-glycinamid, d) deretter avspaltes de beskyttende benzylgrupper i nærvær av en palladiumkatalysator med hydrogen, e) til slutt reduseres produktet med et komplekst hydrid til sluttproduktet.characterized by the following steps: a) a (4-halo-3-alkoxy-but-2E-enoic acid alkyl ester) is reacted with a glycine alkyl ester to a N-[(4-alkoxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycine alkyl ester, b) this is allowed to react further with benzyl alcohol in the presence of an acid, to the intermediate product N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycine alkyl ester, c) this is then reacted with ammonia to N-[(4-benzyloxy-3-pyrrolin-2-one-1-y1)-acetyl]-glycinamide, d) then the protective benzyl groups are cleaved off in the presence of a palladium catalyst with hydrogen, e) finally the product is reduced by a complex hydride to the final product. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at man ifølge trinn a) omsetter en 4-klor-3-(0^ -02 )-alkoksy-but-2E-ensyre-( C^- C^)-alkylester ved temperaturer på 50-80°C, i nærvær av et tertiært amin, fortrinnsvis trietylamin, med en glycinglycin- (C-L-C4) -alkylester, fortrinnsvis som hydroklorid, til en N-[(4-( Ci- C2)-alkoksy-3-pyrrolin-2-on-l-yl)-ace-tyl] -glycin- ( C-^- C^) -alkylester.2. Method according to claim 1, characterized in that, according to step a), a 4-chloro-3-(O^ -O 2 )-Alkoxy-but-2E-enoic acid-(C 1 -C 2 )-alkyl ester is reacted at temperatures of 50-80°C, in the presence of a tertiary amine, preferably triethylamine, with a glycine glycine-(C-L-C4) alkyl ester, preferably as the hydrochloride, to a N-[(4-(C1-C2)-Alkoxy-3- pyrrolin-2-on-1-yl)-acetyl]-glycine-(C-1-C4)-alkyl ester. 3. Fremgangsmåte ifølge krav 1 eller 2, karakterisert ved at man utfører omsetningen med benzylalkohol ifølge trinn b) i nærvær av en sulforsyre, fortrinnsvis metansulfonsyre, ved temperaturer på 80-120°C og trykk på 5-100 mbar.3. Process according to claim 1 or 2, characterized in that the reaction with benzyl alcohol according to step b) is carried out in the presence of a sulfuric acid, preferably methanesulfonic acid, at temperatures of 80-120°C and pressure of 5-100 mbar. 4. Fremgangsmåte ifølge krav 1, 2 eller 3, karakterisert ved at man ikke isolerer N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinalkylesteren, men lar den reagere direkte videre ifølge trinn c) med gassformig ammoniakk ved temperaturer på 20-80°C til det tilsvarende amid.4. Method according to claim 1, 2 or 3, characterized in that the N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycine alkyl ester is not isolated, but allows it to react directly further according to step c) with gaseous ammonia at temperatures of 20-80°C to the corresponding amide. 5. Fremgangsmåte ifølge krav 1, 2, 3 eller 4, karakterisert ved at man hydrogenolyserer N-[(4-benzyloksy-3-pyrrolin-2-on-l-yl)-acetyl]-glycinamidet ifølge trinn d) i nærvær av en palladiumkatalysator med hydrogen ved temperaturer på 0-30°C og til slutt hydrogenerer ifølge trinn e) med et alkaliborhydrid, fortrinnsvis natriumborhydrid, ved temperaturer på 0-30°C til sluttproduktet.5. Method according to claim 1, 2, 3 or 4, characterized in that the N-[(4-benzyloxy-3-pyrrolin-2-on-1-yl)-acetyl]-glycinamide according to step d) is hydrogenolysed in the presence of a palladium catalyst with hydrogen at temperatures of 0-30°C and finally hydrogenates according to step e) with an alkali borohydride, preferably sodium borohydride, at temperatures of 0-30°C to the final product.
NO88883381A 1987-07-30 1988-07-29 PROCEDURE FOR THE PREPARATION OF N - (((4-HYDROSY-PYRROLIDIN-2-ON-1-YL) -ACETYL) -GYLCINAMIDE. NO883381L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH291987 1987-07-30

Publications (2)

Publication Number Publication Date
NO883381D0 NO883381D0 (en) 1988-07-29
NO883381L true NO883381L (en) 1989-01-31

Family

ID=4244565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883381A NO883381L (en) 1987-07-30 1988-07-29 PROCEDURE FOR THE PREPARATION OF N - (((4-HYDROSY-PYRROLIDIN-2-ON-1-YL) -ACETYL) -GYLCINAMIDE.

Country Status (6)

Country Link
EP (1) EP0301398A3 (en)
JP (1) JPS6450894A (en)
DK (1) DK356288A (en)
HU (1) HUT47597A (en)
IL (1) IL87216A0 (en)
NO (1) NO883381L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680293A5 (en) * 1990-06-26 1992-07-31 Lonza Ag

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190378B (en) * 1985-06-21 1988-02-16 Isf Spa PYROLIDONIC DERIVATIVES
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid

Also Published As

Publication number Publication date
EP0301398A2 (en) 1989-02-01
EP0301398A3 (en) 1990-05-30
JPS6450894A (en) 1989-02-27
DK356288D0 (en) 1988-06-28
IL87216A0 (en) 1988-12-30
HUT47597A (en) 1989-03-28
NO883381D0 (en) 1988-07-29
DK356288A (en) 1989-01-31

Similar Documents

Publication Publication Date Title
CA1294736C (en) Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues
SU620206A3 (en) Method of obtaining oxime derivatives or salts thereof
SU965356A3 (en) Process for producing derivatives of (ergolinyl)-n,n-diethylurea or their salts
SU691089A3 (en) Method of producing carbonyl-substituted 1-sulphonylbenzimidazoles
Andreatta et al. Synthesis of the cis and trans isomers of 4-Chloro-L-proline, 4-Bromo-L-proline, and 4-Amino-L-proline
NO329701B1 (en) Process for the preparation of combretastanines and intermediate for the process
US4895943A (en) Preparation of 1,4-diazabicyclo(3.2.2)nonane
NO178028B (en) Process for the preparation of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid and derivatives thereof
NO883381L (en) PROCEDURE FOR THE PREPARATION OF N - (((4-HYDROSY-PYRROLIDIN-2-ON-1-YL) -ACETYL) -GYLCINAMIDE.
US4879393A (en) 4-Benzyloxy-3-pyrrolin-2-on-1-yl acetamide production
EP0285270B1 (en) A method for producing 1-propargyl-2,4-dioxoimidazolidine
US4031108A (en) 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
Cooke et al. The structural rearrangement of iprodione in ethanolic solution
NO772745L (en) PROCEDURES FOR THE PREPARATION OF N-SUBSTITUTED PYRROLIDINES
EP0260588A1 (en) Process for the preparation of alpha-N-[(hypoxanthin-9-yl)-pentyloxycarbonyl]-arginine
NO179903B (en) Process for the preparation of a haloacetamide derivative and a pyrrolidinylacetamide derivative
US6005119A (en) Process for preparing pyrrolidine derivatives
US4855451A (en) 4-benzyloxy-3-pyrrolin-2-one, its production and use for synthesis of tetramic acid
SU1447279A3 (en) Method of producing derivatives of 9-carbamoilfluorene
KR860001906B1 (en) Preparation process for diamino pyridine
US5254733A (en) Process for producing an aliphatic amide and salts thereof
KR930006289B1 (en) Process for preparing dihydrofuranone derivatives
RU2034842C1 (en) Quinoline derivative and a method of its synthesis
SU1409122A3 (en) Method of producing vincubine
IE47805B1 (en) 2,3-dihydro-4h-1-benzopyran-4-one o-carbamoyl oximes